LB Pharmaceuticals Inc Common Stock (LBRX) Live Share Price, Invest From India

LB Pharmaceuticals Inc Common Stock Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$30.85
Day's Price Range
$32.60
$31.16
0.99%
Downside
4.62%
Upside
52 Week's Low
52 Week's High
$13.36
52-Week Price Range
$33.47
$31.16
57.12%
Downside
7.41%
Upside

LB Pharmaceuticals Inc Common Stock share price movements today

Previous Close: $32.70
Open: $32.60
Volume: 410.7K
Day's Low - High: $30.85 - $32.60
52 Week Low - High: $13.36 - $33.47

LB Pharmaceuticals Inc Common Stock Historical Returns

1 Month Return: + 34.33 %
3 Month Return: + 34.27 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

LB Pharmaceuticals Inc Common Stock Stock Fundamentals & Key Indicators

Check LB Pharmaceuticals Inc Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$916.8M

EPS (TTM)

-3.676

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-15.70%

LB Pharmaceuticals Inc Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of LB Pharmaceuticals Inc Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
LB Pharmaceuticals Inc Common Stock	NA	$916.8M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Indian Investors' Interest in LB Pharmaceuticals Inc Common Stock Stock

Search interest for LB Pharmaceuticals Inc Common Stock Stock has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-64% versus previous 30 day period

LB Pharmaceuticals Inc Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	0	-	0	0
Operating Income	-16	-26	-16	-5	-5	-13
EBITDA	-16	-27	-14	-	-3	-13
Interest Expense	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0
Income Before Tax	-16	-27	-14	-5	-3	-11
Income Tax Expense	-	-	-	-	-	0
Net Income	-16	-27	-14	-5	-3	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

LB Pharmaceuticals Inc Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	0
Operating Income	-2	-11	-64	-30
EBITDA	-12	-1	-63	-30
Interest Expense	2	4	-	-
Depreciation	0	0	0	0
Income Before Tax	-14	-6	-63	-25
Income Tax Expense	0	0	0	0
Net Income	-14	-6	-63	-25
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

LB Pharmaceuticals Inc Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-27	-14	-5	-5	-5	-3	-11
Operating Cash Flow	-15	-22	-5	-6	-6	-3	-18
Investing Cash Flow	6	28	-	2	2	-44	0
Financing Cash Flow	0	0	-	-	-	303	-1
Change in Cash	-8	6	7	-	-	255	-19

LB Pharmaceuticals Inc Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-63	-25
Operating Cash Flow	-12	-53	-35
Investing Cash Flow	-28	23	-39
Financing Cash Flow	33	38	302
Change in Cash	-6	8	227

Insights on LB Pharmaceuticals Inc Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, LBRX stock has moved up by 28.6%

About LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Organisation	LB Pharmaceuticals Inc Common Stock
Headquarters	One Pennsylvania Plaza, New York, NY, United States, 10119
Industry	Biotechnology
CEO	Ms. Heather D. Turner Esq., J.D.
E-voting on shares	Click here to vote

Key Management of LB Pharmaceuticals Inc Common Stock

Name	Title
Mr. Zachary Prensky	Co-founder, Advisor to the CEO & Director
Mr. Gad Soffer	Chief Operating & Business Officer
Mr. Marc L. Panoff CPA	Senior Vice President of Finance
Dr. Richard A. Silva Ph.D.	Senior Vice President of Technical Operations
Dr. James Rawls Pharm.D.	Senior Vice President of Regulatory Affairs
Ms. Ellen Rose	Senior Vice President of Corporate Affairs
Ms. Heather D. Turner Esq., J.D.	CEO & Director
Dr. Anna Eramo M.D.	Chief Medical Officer
Ms. Minako Pazdera J.D., Ph.D.	General Counsel
Ms. Lindsay Beaupre	Senior VP of People & Culture

FAQs

What is LB Pharmaceuticals Inc Common Stock share price today?

LB Pharmaceuticals Inc Common Stock share price today is $31.16 as on May 13, 2026 at 1:29 am IST at the close of the market. LB Pharmaceuticals Inc Common Stock share today touched a day high of $32.6 and a low of $30.85.

What is the 52 week high and 52 week low for LB Pharmaceuticals Inc Common Stock share?

LB Pharmaceuticals Inc Common Stock share touched a 52 week high of $33.47 on May 11, 2026 and a 52 week low of $13.36 on September 26, 2025. LB Pharmaceuticals Inc Common Stock stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $31.16,which is 6.90% down from its 52 week high and 133.23% up from its 52 week low.

What is LB Pharmaceuticals Inc Common Stock's market capitalisation today?

LB Pharmaceuticals Inc Common Stock market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in LB Pharmaceuticals Inc Common Stock Stock (LBRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for LB Pharmaceuticals Inc Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in LB Pharmaceuticals Inc Common Stock Shares that will get you 0.0481 shares as per LB Pharmaceuticals Inc Common Stock share price of $31.16 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy LB Pharmaceuticals Inc Common Stock Stock (LBRX) from India?

Indian investors can start investing in LB Pharmaceuticals Inc Common Stock (LBRX) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in LB Pharmaceuticals Inc Common Stock stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:40 am IST). Based on LB Pharmaceuticals Inc Common Stock share’s latest price of $31.16 as on May 13, 2026 at 1:29 am IST, you will get 0.3209 shares of LB Pharmaceuticals Inc Common Stock. Learn more about fractional shares .